"14" . "[305111370E93]" . "Porucha aktivit denn\u00EDho \u017Eivota (ADL) prov\u00E1z\u00ED Alzheimerovu nemoc (AN) a dal\u0161\u00ED demence. A\u010Dkoliv prevalence AN v populaci je vysok\u00E1, onemocn\u011Bn\u00ED je st\u00E1le m\u00E1lo rozpozn\u00E1v\u00E1no. V klinick\u00E9 praxi by vedle vy\u0161et\u0159en\u00ED kognitivn\u00EDch funkc\u00ED m\u011Bla b\u00FDt pozornost zam\u011B\u0159ena i na posouzen\u00ED ADL. Z mnoha r\u016Fzn\u00FDch p\u0159\u00EDstup\u016F jsou vhodn\u00E9 dotazn\u00EDkov\u00E9 metody. Pr\u00E1ce popisuje vlastnosti vhodn\u00E9ho dotazn\u00EDku ADL. P\u0159in\u00E1\u0161\u00ED p\u0159ehled 15 mezin\u00E1rodn\u011B pou\u017E\u00EDvan\u00FDch dotazn\u00EDk\u016F ADL, kter\u00E9 je mo\u017En\u00E9 pou\u017E\u00EDvat u pacient\u016F s demenc\u00ED a popisuje, kter\u00E9 z n\u00E1stroj\u016F jsou k dispozici v \u010Desk\u00E9m prost\u0159ed\u00ED" . . . "ADL, activities of daily living, questionnaires, Alzheimer disease, dementia"@en . "CZ - \u010Cesk\u00E1 republika" . . . . "Porucha aktivit denn\u00EDho \u017Eivota (ADL) prov\u00E1z\u00ED Alzheimerovu nemoc (AN) a dal\u0161\u00ED demence. A\u010Dkoliv prevalence AN v populaci je vysok\u00E1, onemocn\u011Bn\u00ED je st\u00E1le m\u00E1lo rozpozn\u00E1v\u00E1no. V klinick\u00E9 praxi by vedle vy\u0161et\u0159en\u00ED kognitivn\u00EDch funkc\u00ED m\u011Bla b\u00FDt pozornost zam\u011B\u0159ena i na posouzen\u00ED ADL. Z mnoha r\u016Fzn\u00FDch p\u0159\u00EDstup\u016F jsou vhodn\u00E9 dotazn\u00EDkov\u00E9 metody. Pr\u00E1ce popisuje vlastnosti vhodn\u00E9ho dotazn\u00EDku ADL. P\u0159in\u00E1\u0161\u00ED p\u0159ehled 15 mezin\u00E1rodn\u011B pou\u017E\u00EDvan\u00FDch dotazn\u00EDk\u016F ADL, kter\u00E9 je mo\u017En\u00E9 pou\u017E\u00EDvat u pacient\u016F s demenc\u00ED a popisuje, kter\u00E9 z n\u00E1stroj\u016F jsou k dispozici v \u010Desk\u00E9m prost\u0159ed\u00ED"@cs . . . "Dotazn\u00EDky k hodnocen\u00ED b\u011B\u017En\u00FDch \u010Dinnost\u00ED u pacient\u016F s Alzheimerovou nemoc\u00ED"@en . . . . "2"^^ . . "Barto\u0161, Ale\u0161" . "Psychiatrie" . "1"^^ . "255162" . "Dotazn\u00EDky k hodnocen\u00ED b\u011B\u017En\u00FDch \u010Dinnost\u00ED u pacient\u016F s Alzheimerovou nemoc\u00ED"@cs . "I, P(1M0517), P(KAN200520701), P(NS10369), Z(MZ0PCP2005)" . "Dotazn\u00EDky k hodnocen\u00ED b\u011B\u017En\u00FDch \u010Dinnost\u00ED u pacient\u016F s Alzheimerovou nemoc\u00ED" . . . "Dotazn\u00EDky k hodnocen\u00ED b\u011B\u017En\u00FDch \u010Dinnost\u00ED u pacient\u016F s Alzheimerovou nemoc\u00ED"@cs . "1211-7579" . . "Impaired activities of daily living (ADL) are associated with Alzheimer's disease (AD) and other dementias. Although the prevalence of AD in a population is high, the disease is still poorly recognized. In addition to testing of cognitive functions one should focus on the assessment of ADL in clinical practice. Questionnaire method is one appropriate option of the many different approaches. This work describes the characteristics of an eligible ADL questionnaire. It also provides overview of 15 internationally used ADL questionnaires, which can be used in patients with dementia. Some of them are also in their Czech mutation"@en . "4" . "Mart\u00EDnek, P." . . "6"^^ . "Dotazn\u00EDky k hodnocen\u00ED b\u011B\u017En\u00FDch \u010Dinnost\u00ED u pacient\u016F s Alzheimerovou nemoc\u00ED"@en . . "Dotazn\u00EDky k hodnocen\u00ED b\u011B\u017En\u00FDch \u010Dinnost\u00ED u pacient\u016F s Alzheimerovou nemoc\u00ED" . . "RIV/00064173:_____/10:#0000047!RIV11-MZ0-00064173" . . "RIV/00064173:_____/10:#0000047" . . . . .